Bright Minds Biosciences Inc 's

• DRUG's Stock Performance relative to its Competitors

Alzamend Neuro Inc Share Performance -12.11% This Year

Alzamend Neuro Inc Profile Alzamend Neuro Inc is a biopharmaceutical company specializing in the development and commercialization of innovative therapeutics for Alzheimer's disease and other neurological disorders. Their business model revolves around conducting extensive research and clinical trials to develop groundbreaking treatments that address the underlying causes of these debilitating conditions. With a focus on creating value for patients, healthcare providers, and shareholders, they aim to bring effective therapies to market and improve the quality of life for those affected by neurodegenerative diseases. More about Alzamend Neuro Inc 's Market Share

Clearmind Medicine Inc Share Performance -73.61% This Quarter

Clearmind Medicine Inc Profile Clearmind Medicine Inc operates as a healthcare company that provides innovative mental health solutions, leveraging advanced technology and research-backed treatments. Their business model focuses on developing and delivering personalized mental health therapies, utilizing a combination of telehealth services, virtual reality technology, and data-driven treatment plans. More about Clearmind Medicine Inc's Market Share

Compass Pathways Plc Share Performance +6.32% 30 Days

Compass Pathways Plc Profile Compass Pathways Plc is a mental healthcare company focused on developing innovative therapies for treatment-resistant depression. They are pioneering the use of psychedelic-assisted therapy to address this significant unmet medical need. With a business model centered around clinical research and drug development, their goal is to bring their therapies to market and improve the lives of patients suffering from depression. More about Compass Pathways Plc's Market Share

Definium Therapeutics Inc Share Performance -3.20% Over The Past 5 Days

Definium Therapeutics Inc Profile Definium Therapeutics develops pharmaceutically optimized psychedelic drug candidates. More about Definium Therapeutics Inc 's Market Share

Sources: Bright Minds Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 3:22 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bright Minds Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.